查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439278

关节内替代治疗装置 - 全球市场回顾、竞争格局、市场预测（2030）

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2023年全球关节内替代治疗器材市场规模预计为40.8亿美元，到2030年将达到64.3亿美元，2024-2030年预测期内复合年增长率为7.94%，预计将持续增长。 对关节内替代治疗装置的需求不断增长，主要是由于老年人口的增加和骨关节炎患病率的上升，对非手术治疗的需求不断增加，基于透明质酸的疗法的发展取得了进展，并且这是由于明确的报销内部替代疗法的政策。

关节内替代疗法的市场动态

根据世界卫生组织 (WHO) (2022) 的数据，2019 年全球约有 5.28 亿人患有骨关节炎。 根据同一来源，骨关节炎导致 1900 万年残疾 (YLD)。 骨关节炎，也称为“磨损”，会因关节内软骨磨损而引起严重疼痛、肿胀和其他症状。

另外，根据澳洲健康与福利研究所（2020）的报告，2017-2018年，每11名澳洲人中就有1人患有骨关节炎，这一数字约为220万。

因此，由于这些设备有助于减轻关节炎/骨关节炎关节（最常见的是膝盖）的疼痛和肿胀，全球骨关节炎的发病率正在增加。可能会迅速增长关节内替代治疗设备市场。

老年人口的增加是加速关节内替代治疗设备市场发展的另一个因素。 例如，根据世界卫生组织（2022）的数据，到 2030 年，全世界至少六分之一的人将年龄在 60 岁或以上。 到2050年，60岁及以上的人口将达到约21亿人。 根据美国风湿病学会 (2021) 的数据，骨关节炎在老年人中更为常见，其中 40 岁以上的人最容易患骨关节炎。

2019 年4 月，美国食品药物管理局(FDA) 发布了TRILURON□ 的上市前审查，这是一种预先装有透明质酸钠的一次性注射器，可缓解与骨关节炎相关的疼痛长达六个月。菲迪亚製药公司。 因此，产品核准的扩大预计也将推动全球关节内替代治疗市场的发展。

然而，某些因素，例如与透明质酸治疗相关的高成本以及关节内替代疗法缺乏效率，预计将对关节内替代治疗设备市场的成长构成挑战。

关节内替代治疗装置市场区隔分析

在关节内替代治疗产品领域，单次注射预计将在预测期内成为主导领域。

这是因为单次注射黏稠补充疗法产品相对较新，与现有的3-5次注射黏稠补充疗法产品相比也具有成本效益。 例如，一项研究表明，与接受五次标准透明质酸注射的患者相比，接受一次稳定透明质酸注射治疗的患者有统计学上显着的改善。

研究也支持使用单次注射产品治疗膝关节骨关节炎，对医疗保健系统的经济影响有所改善。

此外，主要公司增加投资以改善其产品组合以开发先进产品并保持其在市场中的地位也推动了关节内替代治疗设备市场的细分增长，这是一个促成因素。 例如，2019年3月，Seikagaku在义大利推出了HyLink□，这是一种单次关节内注射黏稠补充剂，用于治疗膝骨关节炎。

因此，上述因素可能会推动对单次注射黏稠补充剂的需求，从而促进 2024-2030 年预测期内关节内替代治疗设备市场的成长。

本报告提供了全球关节内替代治疗设备市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章关节内置换治疗器材市场报告简介

第二章关节内替代治疗设备市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估

第三章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章关节内替代治疗器材市场关键因素分析

  • 关节内替代治疗设备市场驱动因素
    • 骨关节炎盛行率不断上升
    • 对非手术治疗的需求不断增加
    • 玻尿酸产品的进展
    • 有利的赎回
  • 关节内替代治疗设备市场的限制与挑战
    • 关节内替代疗法治疗费用高昂
    • 设备效率低下
  • 关节内替代治疗设备的市场机会
    • 低收入地区的成长机会
    • 公司拓展市场的策略举措

第五章关节内建换治疗装置的波特五力分析

第六章关闭内替代治疗器材市场布局

  • 依产品类型
    • 单次注射
    • 注射 3 次
    • 注射 5 次
  • 按最终用户
    • 医院
    • 骨科诊所
    • 其他
  • 按地区
    • 北美关节内替代治疗设备市场规模（2021-2030）
    • 欧洲关节内替代治疗设备市场规模（2021-2030）
    • 亚太地区关节内替代治疗设备市场规模（2021-2030）
    • 其他地区关节内替代治疗设备市场规模（2021-2030）

第七章关节内替代治疗器材公司及产品简介

  • Anika Therapeutics, Inc.
  • SEIKAGAKU CORPORATION
  • Sanofi
  • Zimmer Biomet
  • Smith & Nephew
  • Ferring B.V.
  • Lifecore Biomedical, LLC
  • LG Chem.
  • Fidia Farmaceutici S.p.A
  • OrthogenRx
  • Bioventus
  • DePuy Synthes (Johnson & Johnson)
  • APTISSEN
  • Vivacy
  • KiOmed Pharma
  • BioPolymer GmbH & Co KG
  • ALBOMED® GmbH

第8章KOL浏览量

第 9 章专案方法

第10章DelveInsight服务内容

第 11 章关于 DelveInsight

第 12 章免责声明与联络我们

Product Code: DIMDCL0068

The viscosupplementation Devices Market By Product Type (Single Injection, Three Injections, and Five Injections), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography is projected to grow at a static CAGR forecast till 2030 due to the growing prevalence of osteoarthritis across the globe and rising demand for non-surgical treatment options for osteoarthritis.

The global viscosupplementation devices market was valued at USD 4.08 billion in 2023, growing at a CAGR of 7.94% during the forecast period from 2024 to 2030, to reach USD 6.43 billion by 2030. The rise in demand for Viscosupplementation Devices is primarily attributed to the rising prevalence of osteoarthritis coupled with the growing old age population, growing demand for non-surgical treatment, increasing advancements in the development of hyaluronic acid-based therapies, and well-defined reimbursement policy for viscosupplements, among others.

Viscosupplementation Devices Market Dynamics:

According to the World Health Organization 2022, worldwide around 528 million people were suffering from osteoarthritis in 2019. As per the same source osteoarthritis contributed to 19 million years lived with disability (YLDs). Osteoarthritis also known as "wear and tear" disease is associated with symptoms such as extreme pain, swelling, and others caused by the wearing down of cartilage within the joints.

Moreover, according to the Australian Institute of Health and Welfare 2020 report, between the years 2017 to 2018, one in eleven Australians have osteoarthritis which makes approximately 2.2 million people in the nation.

Therefore, rising osteoarthritis among the population is likely to surge the global viscosupplementation devices market as these devices help reduce pain and swelling in the arthritic/osteoarthritic joint (most commonly, the knee).

The increasing geriatric population is another factor accelerating the market for viscosupplementation devices market. For instance, according to WHO 2022, it has been expected that, globally by 2030, out of 6 at least 1 person will have his/her age 60 years or above. As per the same source, by 2050, the number of people aged 60 years or above will reach around 2.1 billion. The fact mentioned by the American College of Rheumatology 2021, says that osteoarthritis commonly occurs in the old age population and people aged 40 or above are most likely to suffer from it.

In April 2019, the US Food & Drug Administration (FDA) granted Fidia Pharma premarket approval for TRILURON(TM), a single-use syringe, prefilled with sodium hyaluronate to provide relief to the pain associated with osteoarthritis for up to six months. Thus, growing product approvals is also projected to boost the global market for the viscosupplementation market.

However, certain factors such as the high cost associated with hyaluronic acid therapy and the lack of efficiency of the viscosupplementation devices are expected to pose a challenge to the viscosupplementation devices market growth.

Viscosupplementation Devices Market Segment Analysis:

Viscosupplementation Devices Market By Product Type (Single Injection, Three Injections, and Five Injections), End-User (Hospitals, Orthopaedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the viscosupplementation devices product segment, the single injection is expected to emerge as a foremost segment during the forecasted period.

This is because single injection viscosupplementation products are relatively newer and are also cost-effective in comparison to already existing 3-5 injection viscosupplementation products. For instance, as per research studies, a statistically significant improvement was observed for patients treated with a single stabilized hyaluronic acid injection versus those who received standard hyaluronic acid in five injections.

Also, the studies support the use of single injection products in the treatment of knee OA and found a slight improvement in the economic impact on the healthcare system.

Furthermore, rising investments by key players for improving the product portfolio to develop advanced products and to maintain market position is also a driving factor for the segmental growth of the viscosupplementation devices market. For instance, in March 2019, Seikagaku launched HyLink®, an intra-articular single-injection viscosupplement for the treatment of knee osteoarthritis in Italy.

Thus, the above-mentioned factors are likely to propel the demand for single injection viscosupplementation, thereby contributing to the growth of the viscosupplementation devices market during the forecast period from 2024-2030.

North America is expected to dominate the overall Viscosupplementation Devices Market:

Among all the regions, North America is estimated to account for the largest share of the viscosupplementation devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of osteoarthritis, the growing burden of the old age population, sophisticated healthcare infrastructure, the presence of key players in the market, and fast regulatory approval for new products, in the region, the market for viscosupplementation devices is expected to grow during the forecast period 2024-2030.

The increasing patient population suffering from osteoarthritis is the key factor accelerating the growth of the viscosupplementation devices market in the region. The data published by the Centers for Disease Control and Prevention (CDC) 2020 states that approximately 32.5 million US adults are suffering from osteoarthritis.

The growing burden of the geriatric population is further going to increase the demand for viscosupplementation devices in the region. According to the data provided by the World Bank 2022, about 17% of US citizens aged 65 and above in 2021. Also, according to CDC 2022, around 54.1 million US adults were aged 65 or older in 2019. As per the same source, it has been estimated that by 2060, this number will reach up to 94.7 million in the US. As per the Arthritis by the Numbers report published by the Arthritis Foundation 2019, the risk for knee osteoarthritis increases with age and the annual incidence of knee OA is highest between 55 and 64 years old.

Hence, the above-mentioned factors are going to increase the growth of the viscosupplementation devices market in the region.

Viscosupplementation Devices Market Key Players:

Some of the key market players operating in the viscosupplementation devices market include Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Sanofi, Zimmer Biomet, Smith & Nephew, Ferring B.V., Lifecore Biomedical, LLC, LG Chem, Fidia Farmaceutici S.p.A, OrthogenRx, Bioventus, DePuy Synthes (Johnson & Johnson), Vivacy, APTISSEN, KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED® GmbH and others.

Recent Developmental Activities in the Viscosupplementation Devices Market:

In August 2022, Seikagaku announced the launch of HyLink®, an Intra-Articular Single Injection Viscosupplement for the treatment of knee osteoarthritis in Taiwan.

In January 2022, Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare commercially launched NeoVisc+ 2 mL and NeoVisc ONE 4 mL in Canada for the treatment and improvement of joint functionality and pain in patients suffering from degenerative or mechanical arthropathy of the knees.

Key Takeaway from the Viscosupplementation Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Viscosupplementation Devices Market.

Various opportunities available for the other competitor in the Viscosupplementation Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Viscosupplementation Devices market growth in the coming future?

Target Audience who can be benefited from the Viscosupplementation Devices Market Report Study

Viscosupplementation Devices providers

Research organizations and consulting companies

Viscosupplementation Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in viscosupplementation devices

Various End-users who want to know more about the viscosupplementation devices market and the latest technological developments in the viscosupplementation devices market.

Frequently Asked Questions for Viscosupplementation Devices Market:

1. What are viscosupplementation devices?

Viscosupplementation devices are preparations that have hyaluronic acid filled in an injection, which is administered into the knee joint to relieve pain associated with osteoarthritis.

2. What is the market for global viscosupplementation devices?

The global viscosupplementation devices market was valued at USD 4.08 billion in 2023, growing at a CAGR of 7.94% during the forecast period from 2024 to 2030, to reach USD 6.43 billion by 2030.

3. What are the drivers for the global viscosupplementation devices market?

The major factors driving the demand for viscosupplementation devices are the rising worldwide prevalence of musculoskeletal disorders such as osteoarthritis, the increasing old age population, recent product approvals, and growing demand for non-surgical osteoarthritis treatment, among others.

4. Who are the key players operating in global viscosupplementation devices?

Some of the key market players operating in the viscosupplementation devices market include Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Sanofi, Zimmer Biomet, Smith & Nephew, Ferring B.V., Lifecore Biomedical, LLC, LG Chem, Fidia Farmaceutici S.p.A, OrthogenRx, Bioventus, DePuy Synthes (Johnson & Johnson), Vivacy, APTISSEN, KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED® GmbH, and others.

5. Which region has the highest share in the viscosupplementation devices market?

North America is expected to dominate the overall viscosupplementation devices market. This domination is due to the favorable reimbursement scenario, advanced healthcare infrastructure, and developed research & development facilities in the region.

Table of Contents

1. Viscosupplementation Devices Market Report Introduction

2. Viscosupplementation Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Viscosupplementation Devices Market Key Factors Analysis

  • 4.1. Viscosupplementation Devices Market Drivers
    • 4.1.1. Rising prevalence of osteoarthritis
    • 4.1.2. Increase in demand for non-surgical treatment
    • 4.1.3. Rising advancement in hyaluronic acid-based products
    • 4.1.4. Favorable reimbursement
  • 4.2. Viscosupplementation Devices Market Restraints and Challenges
    • 4.2.1. High cost of the Viscosupplementation Treatment
    • 4.2.2. The inefficiency of the Device
  • 4.3. Viscosupplementation Devices Market Opportunities
    • 4.3.1. Growth opportunities in low-income regions
    • 4.3.2. Strategic initiatives by Companies for Market Expansion

5. Viscosupplementation Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes 5.5 Competitive Rivalry

6. Viscosupplementation Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Single Injection
    • 6.1.2. Three Injections
    • 6.1.3. Five Injections
  • 6.2. By End-User
    • 6.2.1. Hospitals
    • 6.2.2. Orthopedic Clinics
    • 6.2.3. Others
  • 6.3. By Geography
    • 6.3.1. North America Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.1.1. United States Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Viscosupplementation Devices Market Size in USD million (2021-2030)
    • 6.3.2. Europe Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.1. France Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Viscosupplementation Devices Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.1. China Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.3. India Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia Pacific Viscosupplementation Devices Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW) Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.4.1. Middle East Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Viscosupplementation Devices Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Viscosupplementation Devices Market Size in USD million (2021-2030)

7. Viscosupplementation Devices Company and Product Profiles

  • 7.1. Anika Therapeutics, Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. SEIKAGAKU CORPORATION
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Sanofi
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Zimmer Biomet
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Smith & Nephew
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Ferring B.V.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Lifecore Biomedical, LLC
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. LG Chem.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Fidia Farmaceutici S.p.A
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. OrthogenRx
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Bioventus
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. DePuy Synthes (Johnson & Johnson)
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. APTISSEN
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Vivacy
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. KiOmed Pharma
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. BioPolymer GmbH & Co KG
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. ALBOMED® GmbH
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Viscosupplementation Devices Market in Global (2021-2030)
  • Table 3: Viscosupplementation Devices Market in Global by Product Type (2021-2030)
  • Table 4: Viscosupplementation Devices Market in Global by End-User (2021-2030)
  • Table 5: Viscosupplementation Devices Market in Global by Geography (2021-2030)
  • Table 6: Viscosupplementation Devices Market in North America (2021-2030)
  • Table 7: Viscosupplementation Devices Market in the US (2021-2030)
  • Table 8: Viscosupplementation Devices Market in Canada (2021-2030)
  • Table 9: Viscosupplementation Devices Market in Mexico (2021-2030)
  • Table 10: Viscosupplementation Devices Market in Europe (2021-2030)
  • Table 11: Viscosupplementation Devices Market in France (2021-2030)
  • Table 12: Viscosupplementation Devices Market in Germany (2021-2030)
  • Table 13: Viscosupplementation Devices Market in the United Kingdom (2021-2030)
  • Table 14: Viscosupplementation Devices Market in Italy (2021-2030)
  • Table 15: Viscosupplementation Devices Market in Spain (2021-2030)
  • Table 16: Viscosupplementation Devices Market in Rest of Europe (2021-2030)
  • Table 17: Viscosupplementation Devices Market in Asia-Pacific (2021-2030)
  • Table 18: Viscosupplementation Devices Market in China (2021-2030)
  • Table 19: Viscosupplementation Devices Market in Japan (2021-2030)
  • Table 20: Viscosupplementation Devices Market in India (2021-2030)
  • Table 21: Viscosupplementation Devices Market in Australia (2021-2030)
  • Table 22: Viscosupplementation Devices Market in South Korea (2021-2030)
  • Table 23: Viscosupplementation Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Viscosupplementation Devices Market in the Rest of World (2021-2030)
  • Table 25: Viscosupplementation Devices Market in the Middle East (2021-2030)
  • Table 26: Viscosupplementation Devices Market in Africa (2021-2030)
  • Table 27: Viscosupplementation Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Viscosupplementation Devices Market in Global (2021-2030)
  • Figure 3: Viscosupplementation Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Viscosupplementation Devices Market in Global by End-User (2021-2030)
  • Figure 5: Viscosupplementation Devices Market in Global by Geography (2021-2030)
  • Figure 6: Viscosupplementation Devices Market in North America (2021-2030)
  • Figure 7: Viscosupplementation Devices Market in the US (2021-2030)
  • Figure 8: Viscosupplementation Devices Market in Canada (2021-2030)
  • Figure 9: Viscosupplementation Devices Market in Mexico (2021-2030)
  • Figure 10: Viscosupplementation Devices Market in Europe (2021-2030)
  • Figure 11: Viscosupplementation Devices Market in France (2021-2030)
  • Figure 12: Viscosupplementation Devices Market in Germany (2021-2030)
  • Figure 13: Viscosupplementation Devices Market in the United Kingdom (2021-2030)
  • Figure 14: Viscosupplementation Devices Market in Italy (2021-2030)
  • Figure 15: Viscosupplementation Devices Market in Spain (2021-2030)
  • Figure 16: Viscosupplementation Devices Market in Rest of Europe (2021-2030)
  • Figure 17: Viscosupplementation Devices Market in Asia-Pacific (2021-2030)
  • Figure 18: Viscosupplementation Devices Market in China (2021-2030)
  • Figure 19: Viscosupplementation Devices Market in Japan (2021-2030)
  • Figure 20: Viscosupplementation Devices Market in India (2021-2030)
  • Figure 21: Viscosupplementation Devices Market in Australia (2021-2030)
  • Figure 22: Viscosupplementation Devices Market in South Korea (2021-2030)
  • Figure 23: Viscosupplementation Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Viscosupplementation Devices Market in the Rest of the World (2021-2030)
  • Figure 25: Viscosupplementation Devices Market in the Middle East (2021-2030)
  • Figure 26: Viscosupplementation Devices Market in Africa (2021-2030)
  • Figure 27: Viscosupplementation Devices Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Market Opportunities
  • Figure 31: PORTER's Five Force Analysis